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Detection of hypoxia by measurement of DNA damage in individual cells
from spheroids and murine tumours exposed to bioreductive drugs.
H. RSU 1069
PL Olive
British Columbia Cancer Research Centre Vancouver, BC, Canada V5Z JL3.
Summary The ability of the dual-function bioreductive drug, RSU 1069. to identify hypoxic cells in multicell
spheroids and murine SCCVII squamous cell carcinomas was examined using the alkaline comet method. This
method applies fluorescence microscopy and image analysis to measure the amount of migration of DNA from
individual cells embedded in agarose and exposed to an electric field. Chinese hamster V79 spheroids, exposed
for 1 h to RSU 1069, were disaggregated and individual cells were analysed for DNA damage. Following
exposure to RSU 1069, aerobic cells exhibited DNA single-strand breaks while DNA interstrand cross-links
were produced in hypoxic cells. Spheroids containing 40-50% radiobiologically hypoxic cells exhibited
20-30% cells with cross-links and the remainder showed only strand breaks. Similar patterns of damage were
observed in SCCVII tumours growing in C3H mice exposed to 25-200mgkg-'. Subsequent irradiation of
cells in vitro greatly improved the distinction between aerobic and hypoxic cells from spheroids or SCCVII
murine tumours exposed to RSU 1069, especially after treatment with low drug doses. The pattern of damage
was relatively stable for at least 4 h after drug injection. Results indicate that detection of hypoxic cells in solid
tumours may be practical using this agent or a prodrug, PD 144872, selected for phase I clinical testing as a
hypoxic cell radiosensitiser and cytotoxin in human tumours.
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The comet assay, used in conjunction with ionising radiation,
is the only technique currently available which allows
measurement of the radiobiologically hypoxic fraction of a
human tumour (Stone et al., 1993). As discussed in the
companion paper, an important limitation of this method is
the necessity of exposing the tumour to a dose of 3 Gy or
more, followed immediately by fine-needle aspiration. The
possibility that bioreductive drugs which preferentially
damage the DNA of hypoxic cells might also be useful in
identifying hypoxic cells was therefore examined.
In the accompanying paper, DNA damage produced in
individual cells by the bioreductive drug tirapazamine was
shown to be useful in estimating tumour oxygenation. Multi-
cell spheroids and SCCVII murine tumours showed 20-40
times more DNA strand breaks when exposed to this drug
under anoxic than under aerobic conditions. In spheroids
and tumours containing cells with a range of oxygen con-
tents, tirapazamine produced, as expected, a wide range of
cellular responses in terms of DNA damage. However, there
was no clear distinction between aerobic and radiobio-
logically hypoxic cells, making it difficult to determine
hypoxic fraction solely on the basis of the DNA damage
histogram, a method which has proven successful with ionis-
ing radiation-induced DNA damage (Olive and Durand,
1992; Olive et al., 1993; Olive, 1994).
Oxygen inhibits the toxicity of tirapazamine over an ex-
tremely broad range of oxygen concentrations, apparently
extending above 100% (Koch, 1993). The shape of the 'k
curve' describing toxicity as a function of oxygen concentra-
tion may explain why the DNA damage histograms
measured using the comet assay are so broad after tirapaz-
amine treatment. This is not likely to be true for another
bioreductive agent, RSU 1069, since the half-maximum value
on the 'k curve' is about 10-fold lower for RSU 1069 than
for tirapazamine, and toxicity by RSU 1069 shows the most
significant change below 5% oxygen (Koch, 1993). The
hypoxic/oxic differential in cell killing of RSU 1069 can be as
high as 100, although lower differentials have also been
reported for some cell lines (Hill et al., 1986; Stratford et al.,
1986a, b; Whitmore and Gulyas, 1986). Unlike tirapazamine,
this agent produces interstrand cross-links rather than strand
breaks in hypoxic cells because of its bifunctional character
(O'Neill et al., 1987). The aziridine group causes DNA strand
breaks in aerobic cells, while the nitro group at the other end
of the molecule is metabolised under hypoxic conditions and
subsequently bound to macromolecules including DNA
(Silver et al., 1985; Stratford et al., 1986b; Jenner et al.,
1991). The resulting interstrand cross-links should prevent
DNA from migrating during electrophoresis in the comet
assay even when large numbers of DNA single-strand breaks
are present. Since RSU 1069 is also capable of producing
single-strand breaks in aerobic cells, it should be possible to
separate aerobic and hypoxic tumour cells on the basis of the
amount of DNA damage sustained by each cell, with less
damage in hypoxic cells and more damage in aerobic cells.
The following studies describe RSU 1069 damage to the
DNA of cells from multicell spheroids and SCCVII murine
tumours. Since the amount and nature of DNA lesions
measured in vivo is dependent on both rate of induction of
damage and rate of repair, DNA repair kinetics was also
evaluated.
Materials and methods
RSU 1069 [1(2-nitro-l-imidazolyl)-3-aziridino-2-propanol]
was originally supplied by Drs T Jenkins, I Stratford and G
Adams of the MRC Radiology Unit, Chilton, UK. Drug was
dissolved in medium or buffer immediately prior to use. Mice
were injected intraperitoneally with RSU 1069 from a fresh
stock solution of 5 mg ml-' dissolved in phosphate-buffered
saline (PBS).
Methods were identical to those described in the accom-
panying paper on tirapazamine. DNA single-strand breaks
were detected as an increase in tail moment in comets
prepared from cells exposed to RSU-1069 and analysed using
the alkaline comet assay. DNA interstrand cross-links were
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detected by two methods based on the inability of broken
DNA to migrate during electrophoresis when it contains
DNA interstrand cross-links. RSU-1069-treated cells exposed
to 10Gy in vitro exhibited two populations of cells; the
percentage of comets which showed less migration than
expected for exposure to 10 Gy (i.e. tail moments . 11) were
assumed to contain cross-links. Since RSU 1069 also pro-
duces single-strand breaks, exposure to a sufficiently high
dose of this agent also revealed the presence of a separate
population of cells with a low tail moment (.3) which were
considered to contain cross-links.
Results
In Chinese hamster V79 spheroids exposed to 100ligmm-l
RSU 1069, DNA damage was maximum in cells obtained
from well-oxygenated spheroids (Figure lb). Conversely, few
or no strand breaks could be detected in cells from anoxic
spheroids (Figure ld). In spheroids equilibrated with 10%
oxygen and containing about 40% hypoxic cells, there was a
wide variety of responses to RSU 1069 (Figure la and c),
similar to the pattern seen previously for tirapazamine. Other
results have shown that incubation of spheroids with
l00fgmI-1 RSU 1069 under 10% gassing conditions kills
approximately 70% of the cells (Olive et al., 1987). Under
anoxia, virtually all of the cells are killed by this dose, but
under aerobic conditions (in spite of the extensive numbers of
strand breaks) more than half of the cells remain clonogenic.
V79 cells exposed to 50fLgml-1 RSU 1069 under aerobic
conditions for 1 h exhibit an average tail moment of about
15, which is roughly equivalent to the number of strand
breaks produced by 8 Gy (Olive and Banath, 1993).
The presence of DNA interstrand cross-links in hypoxic
cells from RSU 1069-treated spheroids was confirmed by
irradiating single cells obtained from these spheroids contain-
ing 40-50% hypoxic cells. Since the spheroids were disaggre-
gated before irradiation, all of the cells were aerobic and
should have responded identically to ionising radiation.
However, the presence of the cross-links in the irradiated
samples was confirmed when a significant number of cells
showed little or no damage after exposure to 10 Gy (Figure
2). In fact, the use of ionising radiation allowed detection of
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Fugwe 1 DNA damage by RSU 1069 in cells of Chinese hamster
V79 spheroids. Spheroids equilibrated in complete medium with
the gas mixtures indicated were exposed for 1 h to 100Lg ml-g
RSU 1069. Cells recovered by trypsin treatment of spheroids
were analysed for DNA damage using the alkaline comet assay.
(a) A representative bivariate plot of DNA content (total comet
fluorescence) vs tail moment for 200 cells for spheroids exposed
under 10% oxygen. (b-d) Histograms generated from 200 comets
from spheroids incubated with RSU 1069 in medium equilibrated
with the indicated oxygen concentration.
cells with cross-links at much lower drug exposure doses.
Hypoxic cells could be detected in spheroids exposed for 1 h
to 5 Lgml-' RSU 1069 provided the cells were subsequently
given 10 Gy to improve the ability of the assay to identify the
cells with cross-links. In the absence of radiation, there was
no obvious separation between the response of aerobic and
hypoxic cells for doses below 25 jig ml1'. However, once
sufficient numbers of single-strand breaks were produced in
the aerobic cells by higher doses of RSU 1069, the presence
of a separate population of cells containing cross-links could
be identified.
As the dose of RSU 1069 increased, the mean tail momnent
of cells from spheroids also increased up to about
25;Lgml1'. but as the degree of cross-linking increased for
higher doses, further increases in tail moment were not
observed. For spheroids exposed to 100;Lgml-' RSU 1069,
some degree of cross-linking could be present even in the
aerobic population (Figure 3a); the average tail moment for
spheroids exposed to 100 Lgml-' was smaller than for
spheroids exposed to 50jig ml1'. The percentage of cells with
cross-linked DNA was defined on the basis of the responses
of control and 10 Gy-irradiated cells in the absence of drug,
that is the percentage of comets with tail moments . 11 for
the irradiated cells, or with tail moments .3 for the unir-
radiated cells (Figure 3b). In both cases, the percentage of
cells with cross-links averaged 20-30%, a value somewhat
lower than the expected value of 40-50% radiobiologically
hypoxic cells routinely observed for V79 spheroids equili-
brated with 10% oxygen (Durand and Olive, 1992). While
there have been reports of significantly increased numbers of
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Figre 2 Detection of DNA cross-links produced in cells of
spheroids exposed to RSU 1069. V79 spheroids equilibrated with
10% oxygen were incubated for I h with different concentrations
of RSU-1069. Following preparation of a single-cell suspension,
half of the cells were exposed on ice to 10 Gy. Cells were then
analysed for DNA damage using the alkaline comet assay. His-
tograms show the results from 200 comets.strand breaks observed at pH 13 using the filter elution
method (Crump et al.. 1990). increasing the sodium hydrox-
ide concentration in the lysis buffer from 0.03 to 0.3 M
sodium hydroxide did not significantly affect comet migration
patterns (results not shown). The excellent sensitivity of the
comet assay in detecting strand breaks suggests that our lysis
solution, which also contains high salt and ionic detergent. is
sufficient to convert monoadducts to strand breaks.
Repair of DNA single-strand breaks and cross-links by
RSU 1069 was examined using V79 spheroids incubated
under either aerobic or anoxic conditions, nrnsed free of drug
and then returned to aerobic conditions for repair. Single-
strand damage showed a short lag or even an increase in
amount after treatment, but about half of the breaks were
rejoined within 90 min (Figure 4). In contrast. no recovery
was observed over the 2 h repair time for the anoxic cells
containing cross-links (Figure 4).
RSU 1069 also produced DNA damage which was readily
detectable in SCCVII tumours. Initial experiments were per-
formed using an i.p. injection of 100mg kg-' RSU 1069. To
enhance the ability to observe cross-links, the single-cell
suspension was subsequently irradiated with 1OGy on ice.
Results shown in Figure 5 indicate that cross-links were
present 30 mmn to 4 h after injection, with little change in the
percentage of cells with cross-links during this period. While
the proportion of cross-linked cells remained relatively con-
stant 30 mmn to 4 h after injection, the degree of DNA cross-
linking, as indicated by the number of comets with very low
values for tail moments. increased with time, as did the
median damage level for the aerobic population. Almost all
cells exhibited cross-links when tumours were clamped for
I h after RSU 1069 administration; in spite of in vitro
exposure of the cells from this tumour to 10 Gy. little DNA
migration was observed (Figure Sb).
Cross-links could be detected in the absence of the 10 Gy
exposure provided drug doses > 100 mg kg' were injected.
However, doses as low as 25 mg kg-' produced detectable
a
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Fgue 4 Repair of DNA damage produced by RSU 1069. V79
spheroids equilibrated with 21% or 0% oxygen were exposed to
50 Lgml-' RSU 1069 for 1 h. After incubation. spheroids were
washed and returned to spinner culture in medium equilibrated
with air. Samples were removed at specified times and analysed
for DNA damage using the alkaline comet assay. 0. Cells from
spheroids incubated with RSU 1069 in air; 0. cells from
spheroids incubated with RSU 1069 under anoxia prior to repair
in air and irradiation with 10 Gy to detect cross-links. The mean
(s.e.m.) for 100 comets is shown. The upper arrow on the
ordinate shows the average response of the air-incubated cultures
exposed to 1OGy. The lower arrow indicates the average res-
ponse of the anoxic cultures in the absence of 1OGy.
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Figure 3 Dose-response relationship for spheroids exposed to
RSU 1069. (a) Analysis of mean fluorescence from histograms
shown in Figure 2. (b) Caklulation of percentage of cels with
interstrand cross-links, as defined in the Results section. 0, Cells
exposed to RSU-1069 alone; 0, cells exposed to RSU-1069
followed by 10Gy.
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Fire 5 DNA damage by RSU 1069 in SCCVII tumours. Mice
injected i.p. with 100mgkg-1 RSU 1069 were sacrificed at
various times and a single cell suspension was prepared from the
tumour. Cells were then exposed, on ice, to 10 Gy before analysis
of DNA damage using the alkaline comet assay. (a) Cells from
an untreated tumour exposed to 10 Gy. (b) Cells from a tumour
clamped 15 min after injection of RSU 1069, released from the
clamp 1 h later, reduced to a single-cell suspension and exposed
to 10 Gy. (c-f) Cells from tumours removed at the times
indicated after RSU 1069 injection. The percentage of cells
classified as containing cross-linked DNA (tail moment <11) is
shown.
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cross-links when cells were exposed to 10 Gy post-excision.
The proportion of cells with cross-links (defined as comets
displaying a tail moment <11 for irradiated cells or <3 for
unirradiated cells) was relatively constant and independent of
drug dose (Figure 6). In mice allowed to breathe 10% oxygen
during exposure for 90 min to RSU 1069, the percentage of
cells with cross-linked DNA increased to almost 60% (Figure
6, open square).
The toxicity of RSU 1069 in SCCVII tumours was
examined using a clonogenic assay. Hoechst 33342
fluorescence was used as the basis for distinguishing the
position of the cell relative to the functional blood vessels
(Chaplin et al., 1985). While all drug doses produced
significant killing in all cells of the population, more damage
was seen in cells distant from the blood supply (Figure 7).
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Possible diffusion of a toxic product may be responsible for
the effective killing of aerobic as well as hypoxic cells (H-ll et
al., 1989).
Fluorescence-activated cell sorting of tumour cells close to,
as opposed to distant from, the blood supply confirmed that
the cells with the most cross-links were also the cells located
in areas of the tumour most distant from the blood supply
(Figure 8). The comet assay identified the dimly fluorescent
cells as more hypoxic than brightly fluorescent cells following
both tirapazamine and RSU 1069, in spite of the fact that
these two drugs produce opposite patterns of DNA damage;
this result further validates the cell sorting method. There is
also a suggestion from these data of the presence of sub-
populations of cells with different degrees of DNA cross-
linking which may be expected in this tumour which under-
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Figwe 6 Percentage ofcells containing cross-links after exposure
of SCCVII tumnours to RSU 1069. Tumours excised from mice
30 min to 4 h after treatment were examined for the presence of
cross-links, defined as the percentage ofcomets with tail moments
<II for cells exposed to lO Gy after excision (0), or tail
moments <3 for tumours exposed to RSU 1069 alone (V). The
open square shows the result for tumours of mice breathing 10%
oxygen during the 90 min drug treatment. The mean (s.d.) for
three or more tumours is shown.
Fge 7 Survival of SCCVII tumour cells exposed to RSU
1069. Mice injected i.p. with RSU 1069 were injected int-
ravenously 90 min later with Hoechst 33342. Tumours were
removed to ice-cold buffer and a single-cell suspension was
prepared. Single cells were sorted on the basis of the Hoechst
33342 fluorescence gradient into brightly and dimly staining cells
representing tumour cells close to and distant from blood vessels
respectively. Results from two tumours per dose point are
shown.
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Fugre 8 DNA damage by RSU 1069 in tumour cells close to or distant from the blood supply. Mice were injected with 50 or
100 mg kg'l RSU 1069 approximately 90 min before Hoechst 33342 injection and tumour excision. Cell sorting on the basis of the
Hoechst 33342 diffusion gradient was used to separate cells into the 10% most dimly fluorescent and the 10% most brightly
fluorescent cells or all of the cells were examined. Duplicate samples were exposed to 1OGy after sorting, and all cells were
analysed for DNA damage using the alkaline comet assay.
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-goes transient fluctuations in perfusion (Chaplin et al., 1987).
The application of 10 Gy post excision considably im-
proved sensitivity, especialy for doses <50mg kg-'. As was
observed for spheroids, increasing concentrations of RSU
1069 caused an increase in mean tail moment for both dimly
and brightly fluorescent cells (Figure 9a). Exposure of the
singkl-cell suspension to Gy reveals the greater degree of
cross-linking in the dimly fluorescent population. In addition,
there is a reasonable correlation between the average tail
moment in the dimly and brightly fluorescent cells and cell
survival in these populations (Figure 9b).
DNA damage by RSU 1069 can be used to identify hypoxic
cells in spheroids and tumours: single-strand breaks are pro-
duced in aerobic cells and probably also in hypoxic cells, but
DNA intstrand cross-linis are produced only in hypoxic
cells. After exposure to high drug concentrations, the distri-
bution of cells with different amounts of DNA damage can
be used to identify the relevant hypoxic population, assuming
that cells with cross-links are hypoxic. DNA damage by RSU
1069 shows a fairly good correlation with cell killing. How-
ever, it is clear that aerobic as well as hypoxic cells are
susceptible to killing and DNA damage by this agent. Thus,
while the percentage of cells with cross-linis remains
relatively constant with increasng time or dose, some of the
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Fugwe 9 Comparison between toxicity and DNA damage for
sorted populations of tumour cel cxposed to RSU 1069. (a)
Dose-response for cells from tumours cxposed to RSU 1069
approximately 90mmm before excion, or for lls xcposed to
1OGy after sorting_ (b) Comparison between tail moment and
surviving fration for tumour cells from mice exposed to RSU
1069 (V, 10%/. dimly fluorcent cells; 0, 10% brightly fluor-
escent cells; 0, unsorted cells).
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aerobic cells must also be dying. Like tirapazamine, it seems
that DNA damage by RSU 1069 may be a better indicator of
cellular oxygenation than cell killng. By comparing histo-
grams of DNA damage produced for spheroids with those
produced for SCCVH tumours, it is possible to determine a
dose in each tumour model which produces a similar amount
of DNA damage. In spheroids, exposure to 251g mll' for
1 h produces a histogram similar to that observed from cells
of SCCVH tumours 90 min after i.p. injection of
100mgkg-'.
V79 spheroids equiibrated with 10% oxygen routinely
show a radiobiological hypoxic fraction of about 40-50%.
The percentage of cells labelled 'hypoxic' by virtue of the
presence of cross-links was only about 20% in spheroids
treated by RSU 1069 alone. In spheroid cells exposed -to
10Gy after drug treatment, the presence of cross-links could
be detected after much lower doses, and using a cut-off of 11
the 'hypoxic' fraction increased to about 30%. The percent-
age of heavily cross-linked cells underestimates the radio-
biologicllly hypoxic fraction because the relation between
oxygen concentration and DNA damage by RSU 1069 is
likely to differ from the relation between oxygen concentra-
tion and ionising radiation-induced DNA damage. The shape
of the curve describing RSU 1069 toxicity vs oxygen concen-
tration shows a half-maximum value considerably lower than
that observed for ionising radiation (Koch, 1993). Broaden-
ing the definition of a cell with cross-links to incude those
cells with minimal numbers ofcross-linis should improve the
ability of RSU 1069 to detect radioresistant hypoxic cells in
vivo.
Results obtained using SCCVII tumours agree well with
the spheroid results. Doses <I00 mgkg-' produced too few
strand breaks in aerobic cells to allow separation of aerobic
and hypoxic populations. However, upon irradiation of the
tumour cell suspension, the presence of cross-links in some
cells of the population could be easily resolved, even after
exposure to a relatively non-toxic dose of 25mgkg-'. The
percentageof cells with tail moments < 11 was 20 ± 3.76%
(mean ±s.e.m. for 17 tumours). The criterion for the cut-off
was based on the observation that fewer than 5% of the cells
from untreated tumours exposed to 1OGy in vitro showed
tail moments less than 11. This percentage of cross-linked
cells measured using RSU 1069 is in good agreement with the
hypoxic fraction ofthe SCCVH tumour determined by paired
survival curve analysis, or using the comet assay in conjunc-
tion with ionising radiation-induced damage; in these
experiments, the hypoxic fraction was approximately 12%
and 18% respectively (Olive and Durand, 1992; Olive,
1994).
RSU 1069 appears to have some favourable characteristics
in comparison with tirapazamine for identifying hypoxic cells
in tumours and tissues. The distnction between aerobic and
hypoxic cells is less subjective. Once the population of drug-
treated tumour cells is irradiated n vitro, the percentage of
cells with tail moments less than the irradiated controls (i.e.
tail moment < 11) can be defined as hypoxic. Since virtually
every cell type shows the same number of single-strand
breaks after exposure to lOGy in vitro, routine use of a
control sample (i.e. 1OGy irradiated, no drug treatment) is
not necessary. In comparison, the relation between tira-
pazamine toxicity and oxygen tension changes continually
over a wide range of oxygen concentrations (Koch, 1993),
making it difficult to distinguish the sig nt hypoxic frac-
tion. A second advantage relates to the rate of repair of
DNA damage by these bioreductive drugs. While half of the
tirapazimine breaks were rejoined within 1 h after drug treat-
ment, no repair of RSU 1069 cross-links was seen for up to
4 h following drug treatment, providing a much longer
sample window and simplifying interpretation of results. A
third benefit is that irradiation of cells (once extracted from
the tumour) greatly nhances the ability to detect hypoxic
cells containing RSU 1069 cross-links thus reducing the
amount of drug required. Whie the gastrointesinal toxicty
of RSU 1069 precludes the use of this drug in the clinic, RB
6145 and its isomer PD 144872 are less emetic compoundsTimwshoods ode flU US
542PL 0
so2
which act as prodrugs for RSU 1069, and will advance to
clinical trial (Cole et al., 1992; Sebolt-Leopold et al., 1992;
Bremner, 1993). Since RB 6145 is converted to RSU 1069
with a half-time of less than 2mi at 3TC (Binger and
Workman, 1991), we can be asured that results with RSU
1069 will also apply to the prodrug chosen for clinical test-
ing.
A final consideration in comparing tirapazamine and RSU
1069 as indicators of hypoxia is that hypoxic cells show klss
DNA damage than aerobic cells after RSU 1069 treatment,
but more damage than aerobic des after i zamine
exposure. The fact that the cells ofinterest, the hypoxic cells,
show a smaller tail moment after RSU 1069 can be advan-
tageous since some tumours (espeially during thrapy) may
accumulate significant numbers of heavily damag clls
which might be mistakenly con hypoxic following
treatment with tirapaamine.
The kinetics of strand break and cross-link repair was
somewhat unusual in that cross-link damage was stable,
while strand breaks appeared to show a delay or even an
increase in damage prior to rejoining (Figure 4). These
kinetics can be compared with those obtained by Jenner et al.
(1991) using alkln or neutal sucrose gradient sedimenta-
tion to detect single- or double-stand breaks in V79 cells
exposed to much higher doses (0.4 to 2mm RSU 1069).
Their results indicate little or no rejoining of sin -and
breaks over a 3 h period, and an actual increase in the
number of double-strand breaks during this period. While
the chemical nature of the DNA lsions beng evahlated by
the comet assay may differ, it is clear from both these studies
that damage by RSU 1069 is not easily repaired.
Like tirapazamine, the difference in response to RSU 1069
between poorly perfsied and well-perfised cells is impressive.
Hoechst 33342 injection prior to sorting stains those cells
close to functional blood vessels at that point in time, since
the plasma half-ife ofthis drug is less than 2 min (Chapln et
al., 1987). However, both tiapzmie and RSU 1069 have
plasma half-lives of about 20-30mn (Workman and Wal-
ton, 1984; Walton and Workman, 1993); as cells cycle in and
out of hypoxia, they can still generate active spece that
cause DNA dam . For a similar reason, infusion of
Hoechst during irradiation signintly improved the ability
of the sorting method to detect cells resistant to killng by
X-rays (Chaplin et al., 1987).
In summary, RSU 1069 produces DNA cross-links in hy-
poxic cells that can be det d using the alkalin comet
assay. Irradiation of the single-l suspension obtained from
tumours after drug treatment provides additional sensitvity
for detecting cells with cross-links. There appears to be good
potential for the applicton ofthis method to detect hypoxic
cells in human tumours exposed to the less emetic prodrug,
PD144872.
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